HuGE Literature Finder
Records
1
-
5
CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a Japanese population. Digestive diseases and sciences 2009 Mar . Tahara T, Shibata T, Hirata I, Nakano H, Arisawa T |
CD14 expression in the first 24h of sepsis: effect of -260C>T CD14 SNP. Immunological investigations 2008 37 (8): 752-69. de Aguiar Bibiana Butkus, Girardi Ingrid, Paskulin Diego D'Avila, de Franca Everaldo, Dornelles Cláudia, Dias Fernando Suparregui, Bonorino Cristina, Alho Clarice Sampa |
Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clinical and experimental immunology 2002 May 128 (2): 326-32. Karhukorpi J, Yan Y, Niemela S, Valtonen J, Koistinen P, Joensuu T, Saikku P, Karttunen |
CD14 receptor polymorphism and Alzheimer's disease risk. Neuroscience letters 0 380 (1-2): 193-6. Combarros Onofre, Infante Jon, Rodríguez Eloy, Llorca Javier, Peña Nicolás, Fernández-Viadero Carlos, Berciano Jo |
TLR2-TLR4/CD14 polymorphisms and predisposition to severe invasive infections by Neisseria meningitidis and Streptococcus pneumoniae. Medicina intensiva / Sociedad Española de Medicina Intensiva y Unidades Coronarias 0 38 (6): 356-62. Tellería-Orriols J J, García-Salido A, Varillas D, Serrano-González A, Casado-Flores |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: